Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
LNSR
#3130
LENSAR, Inc. Common Stock
11.9
7
-0.66%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-0.66%
Variazione Mensile
-3.86%
Variazione di 6 mesi
-1.89%
Variazione Annuale
+7.55%
Chiusura Precedente
12.0
5
Open
11.9
7
Bid
Ask
Low
11.9
7
High
11.9
7
Volume
17
Mercati
Mercato Azionario Statunitense
Salute
LNSR
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Cash from operating activities
-3.15 M
-3.66 M
6.94 M
5 M
3.51 M
11.79 M
Cash from investing activities
905 K
-1.99 M
531 K
6.43 M
-4 M
969 K
Cash from financing activities
93 K
-16 K
9.69 M
93 K
0
9.77 M
Free cash flow
-3.17 M
-3.66 M
6.93 M
4.92 M
3.51 M
11.71 M
Notizie
Abschluss der LENSAR-Übernahme durch Alcon auf erste Jahreshälfte 2026 verschoben
LENSAR-Alcon deal closing pushed to first half of 2026
Lensar: Timing And Arbitrage Considerations In Alcon's Acquisition Bid (NASDAQ:LNSR)
LENSAR: EPS verfehlt Schätzungen um 0,26 $ - Umsatz schlechter als erwartet
LENSAR earnings missed by $0.26, revenue fell short of estimates
LENSAR earnings missed by $0.08, revenue fell short of estimates
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019 - Alcon (NYSE:ALC)
Alcon: A Clear Vision, But Fully Valued (NYSE:ALC)
Alcon Eyes Surgical Edge With LENSAR Buyout: Details - LENSAR (NASDAQ:LNSR), Alcon (NYSE:ALC)
LENSAR stock surges 23.7% as Q4 revenue beats estimates